Generic Lotrel Blocked

May 24, 2007

On May 18th the FDA granted a final approval to Teva of its AB rated Lotrel generic, and they immediately started shipping the product.

Then On May 19, the US District Court granted Novartis an emergency request for a temporary order restraining Teva’s launch. The temporary order is in place until May 29 and stopps Teva from shipping any further generic copies of the medication.

However, the judge has allowed Teva to continue to sell any generics of Lotrel that had reached distributors and customers before the restraining order was placed.

Continue to check CPhTLink.com for further updates on this and other stories.

Comments

One Response to “Generic Lotrel Blocked”

  1. Andrew on June 15th, 2007 10:28 am

    Just to let you know, Teva and Novartis have reached an agreement allowing Teva to market the generic Lotrel, and another compant (Sandoz, I think) is making an “authorized” generic.

Got something to say?